Want to see IN:SMSPHARMA full AI Analyst Report?

SMS Pharmaceuticals Limited (SMSPHARMA) Financial Statements

3 Followers

SMS Pharmaceuticals Limited Financial Overview

SMS Pharmaceuticals Limited's market cap is currently ₹39.10B. The company's EPS TTM is ₹9.69; its P/E ratio is 36.89; and it has a dividend yield of 0.13%. SMS Pharmaceuticals Limited is scheduled to report earnings on May 22, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 8.87B	₹ 7.83B	₹ 7.09B	₹ 5.22B	₹ 5.15B
Gross Profit	₹ 1.75B	₹ 1.45B	₹ 2.11B	₹ 1.29B	₹ 1.81B
Operating Income	₹ 1.31B	₹ 1.03B	₹ 1.34B	₹ 213.40M	₹ 789.84M
EBITDA	₹ 1.71B	₹ 1.45B	₹ 1.18B	₹ 593.89M	₹ 1.20B
Net Income	₹ 1.02B	₹ 691.36M	₹ 498.26M	₹ -70.59M	₹ 622.20M
Balance Sheet
Cash & Short-Term Investments	₹ 460.75M	₹ 415.86M	₹ 361.16M	₹ 73.78M	₹ 465.83M
Total Assets	₹ 13.62B	₹ 11.53B	₹ 10.34B	₹ 8.80B	₹ 8.60B
Total Debt	₹ 3.65B	₹ 3.11B	₹ 2.81B	₹ 2.54B	₹ 2.63B
Net Debt	₹ 3.19B	₹ 2.69B	₹ 2.45B	₹ 2.47B	₹ 2.17B
Total Liabilities	₹ 5.77B	₹ 5.13B	₹ 4.98B	₹ 4.19B	₹ 3.89B
Stockholders' Equity	₹ 7.86B	₹ 6.40B	₹ 5.36B	₹ 4.61B	₹ 4.70B
Cash Flow
Free Cash Flow	₹ -926.46M	₹ -588.57M	₹ -20.35M	₹ -74.71M	₹ 129.86M
Operating Cash Flow	₹ 379.12M	₹ 645.23M	₹ 501.25M	₹ 224.50M	₹ 402.34M
Investing Cash Flow	₹ -1.32B	₹ -1.24B	₹ -520.72M	₹ -296.86M	₹ -271.53M
Financing Cash Flow	₹ 981.46M	₹ 644.32M	₹ 306.79M	₹ -319.69M	₹ -69.21M

Currency in INR

SMS Pharmaceuticals Limited Earnings and Revenue History

Income Statement >

SMS Pharmaceuticals Limited Debt to Assets

Balance Sheet >

SMS Pharmaceuticals Limited Cash Flow

Cash Flow >

SMS Pharmaceuticals Limited Forecast EPS vs Actual EPS

Earnings >